SPONSOR
National Cancer Center, Korea
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 3
Conditions studied: Ovarian CancerEarly Gastric CancerAdenocarcinoma of the StomachProximal Gastric CancerSPADE OperationReflux Esophagitis PreventionLaparoscopic Proximal GastrectomyQuality of LifeGastric Function PreservationAdvanced Hepatocellular Carcinoma (HCC)
National Cancer Center, Korea is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Ovarian Cancer, Early Gastric Cancer, Adenocarcinoma of the Stomach, Proximal Gastric Cancer.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Cancer Center, Korea
How many clinical trials has National Cancer Center, Korea sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by National Cancer Center, Korea, of which 4 are actively recruiting participants. These trials cover conditions including Ovarian Cancer, Early Gastric Cancer, Adenocarcinoma of the Stomach. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Cancer Center, Korea research focus on?
National Cancer Center, Korea clinical trials span Ovarian Cancer, Early Gastric Cancer, Adenocarcinoma of the Stomach, Proximal Gastric Cancer, SPADE Operation, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Cancer Center, Korea clinical trial?
To participate in a National Cancer Center, Korea trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Cancer Center, Korea trials with current recruitment status updated daily.
Clinical Trials by National Cancer Center, Korea
NCT07171528 Phase 2
Recruiting
Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer
Ovarian Cancer
NCT05827523 Phase 3
Recruiting
Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)
Ovarian Cancer
NCT07892183
Recruiting
SPADE Clinical Trial.
Early Gastric Cancer
NCT06828380 Phase 2
Recruiting
A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion
Advanced Hepatocellular Carcinoma (HCC)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology